glp-1 pediatric obesity RAs hold promise for obesity, MASLD; barriers persist | AAP News Pediatric obesity drug use increased
Description
Feb 23, 2026 On paper, these three medications look like variations of the same thing
If nausea remains severe at this point, discuss with your provider before advancing doses
The risk of taking these medications is significant because users have no way of knowing if theyre receiving the correct dosage or if the ingredients are safe
[DOI] [PubMed] [Google Scholar] 66.Jeppesen PB, et al
Rodent models of heart failure
A small number of users report mild appetite reduction
